Compare Bio Protocol (BIO) vs GMX (GMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs GMX — how do they compare? Bio Protocol trades at Rp434.77 (market cap Rp999,49M, Rp162,68M 24h volume), while GMX trades at Rp120,816 (market cap Rp1,27T, Rp42,46M 24h volume). The key difference: GMX is far larger — about 1270.6× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 10,5M / 13,3M GMX (79%) for GMX. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and GMX for 46 Days on average.
| BIO | GMX | |
|---|---|---|
Market Cap | Rp999,49M | Rp1,27T |
Volume (24h) | Rp162,68M | Rp42,46M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 10,5M / 13,3M GMX (79%) |
Typical Hold Time | 18 Days | 46 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
GMX is trading at Rp119,168 with a market cap of Rp1.25T, showing bullish technical signals with strong moving average support and neutral oscillators. The token maintains 79% circulation with 10.5 million GMX in supply. Current price sits above pivot point Rp118,693 with key resistance at Rp120,626. No major protocol updates reported recently, but the asset demonstrates solid technical positioning within the DeFi derivatives ecosystem.
Overall outlook remains cautiously optimistic given strong technical momentum, though RSI levels suggest potential overbought conditions. Key opportunities include continued DeFi adoption and protocol utility growth, while risks involve crypto market volatility and regulatory uncertainty. Investors should monitor support at Rp117,548 for trend confirmation.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About GMX
GMX is a decentralized exchange (DEX) for trading perpetual cryptocurrency futures with up to 50X leverage on popular cryptocurrencies like BTC, ETH and more. The platform launched in September 2021 as Gambit Exchange. To date, GMX has a total trading volume of over $130B and 283K total users, making it the leading derivatives DEX on Arbitrum and Avalanche.
Read more on GMX →
